STOCK TITAN

OneMedNet Signs New Network Partnership Agreement with One of the Largest Private Hospital Operators in U.S.

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership
Rhea-AI Summary
OneMedNet Corporation (ONMD) partners with a large-scale healthcare system to enhance real-world data availability for life science innovation. The partnership aims to advance new diagnostic and treatment solutions by leveraging regulatory-grade imaging Real World Data (iRWD). This collaboration expands the partner network by 15%, enabling faster and more accurate data delivery to customers.
Positive
  • None.
Negative
  • None.

The strategic partnership announced by OneMedNet is a significant development for stakeholders in the healthcare and life science sectors. The integration of a large-scale, multi-state healthcare system into OneMedNet's iRWD network represents a notable expansion in the company's data curation capabilities. Real World Data (RWD) is increasingly vital for the advancement of medical research and the development of new treatments. The ability to access a broader and more diverse dataset can potentially shorten development timelines and enhance the precision of clinical research, ultimately leading to more targeted and effective therapies.

From a market perspective, the expansion of OneMedNet's partner network by approximately 15% is substantial. This growth could signal increased revenue potential and a stronger competitive position in the market for RWD. For investors, the ability of OneMedNet to fulfill customer orders more rapidly and extensively may translate into improved financial performance and an enhanced value proposition for the company's shares.

The partnership underscores the importance of high-quality, interpretable and accurate data in the life sciences industry. The demand for specific, multi-variable and longitudinal data is critical for organizations involved in drug development, medical device innovation and clinical research. The ability to match data with such precision is a key differentiator for OneMedNet, potentially positioning the company as a leader in the iRWD space.

For medical researchers, the expansion of the iRWD network means access to a larger repository of imaging data across specialties such as Neurology, Orthopedics, Oncology and Cardiology. This breadth of data can enhance the quality of observational studies, post-market surveillance and real-world evidence generation, which are crucial for regulatory submissions and the optimization of therapeutic interventions.

The partnership's impact extends beyond immediate business implications to broader economic considerations within the healthcare industry. The efficient utilization of RWD can lead to cost savings by reducing the need for extensive clinical trials and enabling more effective resource allocation. Furthermore, the expanded network could drive innovation and efficiency within the healthcare system, potentially lowering healthcare costs and improving patient outcomes.

By providing a more accurate and extensive dataset, OneMedNet may contribute to a shift in healthcare towards evidence-based practices, personalized medicine and value-based care models. This shift could have long-term economic implications, including changes in healthcare spending patterns and the potential for more sustainable growth within the life science and healthcare sectors.

~ Partnership Will Significantly Expand Depth and Diversity of Real World Data Availability for Life Science Innovation ~

MINNEAPOLIS, Feb. 29, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“iRWD”), today announced a partnership with a large-scale, multi-state healthcare system to advance the development of new diagnostic and treatment solutions using OneMedNet’s iRWD™. Pharmaceutical, AI, medical device, and clinical research organizations are increasingly leveraging the use of existing real world data across many stages of development from ideation up to and including post-market surveillance.

“Life science organizations have experienced tremendous benefit in utilizing RWD in their innovation process and go-to-market execution,” said Aaron Green, OneMedNet President. “The challenge they all face is getting access to diverse high quality data that is interpretable and flawlessly accurate. Importantly, we not only provide Life Science organizations with more accurate data, we also enable more accurate decision-making.”

This new partner has over 30 hospitals spread across 9 states and serves over 2 million people annually with noteworthy specialty clinics in the fields of Neurology, Orthopedics, Oncology and Cardiology. The addition of this organization has increased our partner network by approximately 15% and is accelerating our ability to provide the specific data our customers need. This allows OneMedNet to fulfill customer orders faster and more broadly than has been done in the past.

Often, life science innovators require data that is extremely specific with precise multi-variable and multi-level matching on a longitudinal scale. In order to meet these requirements, the RWD curating company must have a massive network and the ability to add new partners quickly. With OneMedNet’s indexing platform and unparalleled data curation team, OneMedNet is at the forefront in providing RWD, inclusive of imaging, to the market.

The OneMedNet iRWD™ network consists of over 235 healthcare systems and providers who not only provide state-of-the-art patient care today, but also want to be the transformational driver for impactful and measurable care improvements tomorrow.

About OneMedNet Corporation 

Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing its proven OneMedNet iRWD™ solution, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements. For more information, please visit www.onemednet.com.

Investor Contact

Shannon Devine
MZ Group North America
203-741-8811
ONMD@mzgroup.us

SOURCE: ONEMEDNET CORP. 


The ticker symbol of OneMedNet Corporation is ONMD.

OneMedNet provides regulatory-grade imaging Real World Data (iRWD) to enhance life science innovation.

OneMedNet's iRWD network consists of over 235 healthcare systems and providers.

The partnership expands the partner network by approximately 15%, allowing faster and more accurate data delivery to customers.

The new partner of OneMedNet serves specialty clinics in Neurology, Orthopedics, Oncology, and Cardiology.
OneMedNet Corp.

NASDAQ:ONMD

ONMD Rankings

ONMD Latest News

ONMD Stock Data

Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services